NCT04569487View on ClinicalTrials.gov

Identification of Relevant Biological, Imaging, Mobility and Clinical Markers for Clinical Research in Sarcopenia

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions
Sarcopenia
Interventions
PROCEDURE

Biopsy

Muscle biopsy from vastus lateralis (100-200 mg from non-dominant leg)

Trial Locations (2)

1070

Erasme Hospital, Brussels

1090

Universitair Ziekenhuis Brussel, Brussels

Sponsors

Lead Sponsor

Artialis
All Listed Sponsors
lead

Artialis

INDUSTRY

NCT04569487 - Identification of Relevant Biological, Imaging, Mobility and Clinical Markers for Clinical Research in Sarcopenia | Biotech Hunter | Biotech Hunter